Aguirre A de Cubas

4PUBLICATIONS
35CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 30, 2026
SETD2 Deficiency Drives Mitochondrial DNA Leakage and Creates a Druggable Dependency on BCL-xL in Clear Cell Renal Cell Carcinoma.

|Apr 30, 2024
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects.

Alexandria P Eiken, Audrey L Smith, Sydney A Skupa

|Apr 15, 2024
High affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells.

Russell W Cochrane, Rob A Robino, Bryan Granger

|Mar 27, 2023
Immunogenicity in renal cell carcinoma: shifting focus to alternative sources of tumour-specific antigens.

Melissa M Wolf, W Kimryn Rathmell, Aguirre A de Cubas

Pageof 1

Frequent Collaborators

1 joint publications

W Kimryn Rathmell

1 joint publications

Russell W Cochrane

1 joint publications

Rob A Robino

1 joint publications

Bryan Granger